Skip to main content

Table 2 Baseline demographic and clinical characteristics in individuals with progressive glycemic impairment compared to no change at 2.5 years

From: Circulating micrornas associated with glycemic impairment and progression in Asian Indians

Characteristics Mean ± SD, Median (IQR), or n (%) Progressive Glycemic Impairment (n = 23) No Change (n = 71) p-value
Sex (male) 14 (61) 41 (58) 0.070
Age (years) 55 ± 9 57 ± 9 0.310
Current Smoking 8 (9) 3 (4) 0.705
Physical Activity (MET-minutes/week) 1260 (473, 2100) 1470 (613, 2940) 0.293
Systolic Blood Pressure (mm Hg) 119 ± 20 122 ± 17 0.420
Diastolic Blood Pressure (mm Hg) 71 ± 13 71 ± 10 0.942
Total Cholesterol (mg/dL) 188 ± 39 188 ± 29 0.955
LDL-c (mg/dL) 113 ± 33 112 ± 27 0.872
HDL-c (md/dL) 51 ± 16 50 ± 14 0.780
Triglycerides (mg/dL) 120 ± 65 126 ± 56 0.676
Fasting Blood Glucose (mg/dL) 91 ± 8 91 ± 11 0.813
Insulin (μIU/mL) 11.5 ± 6.2 11.5 ± 6.2 0.807
HOMA-IR (μIU/mL*mmol/L) 2.6 ± 1.5 2.8 ± 2.1 0.715
Body Mass Index (kg/m2) 25.7 ± 4.7 25.9 ± 4.5 0.878
Waist Circumference (cm) 93 ± 12 94 ± 12 0.856
  1. cm centimeters, HDL-c high density lipoprotein cholesterol, HOMA-IR homeostasis model assessment-insulin resistance, kg/m 2 kg per meter2, LDL-c low density lipoprotein cholesterol, mcU/mL microUnit per milliliter, mg/dL milligrams per deciliter, mm Hg millimeters of mercury, SD standard deviation